Saturday, October 31, 2026

Cognizant Technology Solutions And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Cognizant Technology Solutions  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Microchip Technology (MCHP), Summit Financial Group (SMMF), Cooper Companies (COO) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Microchip Technology (MCHP)

25.9% sales growth and 6.4% return on equity

Microchip Technology Incorporated develops, manufactures, and sells semiconductor products for various embedded control applications in the Americas, Europe, and Asia.

Microchip Technology's sales growth this year is expected to be 16.6% and 5.6% for next year.

Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 5.44B for the twelve trailing months.

Volume

Today's last reported volume for Microchip Technology is 1815420 which is 4.09% above its average volume of 1744140.

Microchip Technology's sales growth is a negative 0% for the current quarter and 25.9% for the next. The company's growth estimates for the ongoing quarter and the next is 21.8% and 27.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.4%.

Volatility

Microchip Technology's last day, last week, and last month's current volatility was 4.43%, 1.98%, and 1.54%, respectively.

Microchip Technology's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.21% (day), 2.62% (last week), and 2.48% (last month), respectively.

Microchip Technology's Stock Yearly Top and Bottom Value

Microchip Technology's stock is valued at $133.76 at 23:22 EST, way under its 52-week high of $166.67 and way higher than its 52-week low of $95.53.

Microchip Technology's Moving Average

Microchip Technology's worth is way under its 50-day moving average of $149.67 and way below its 200-day moving average of $149.89.

2. Summit Financial Group (SMMF)

19.1% sales growth and 13.53% return on equity

Summit Financial Group, Inc. operates as a financial holding company for Summit Community Bank, Inc. that provides community banking and other financial services to individuals and businesses primarily in the Eastern Panhandle, Southern and North Central regions of West Virginia and the Northern, and Shenandoah Valley and Southwestern regions of Virginia, and the Central region of Kentucky.

Summit Financial Group's sales growth this year is anticipated to be 22.1% and 0.4% for next year.

Year-on-year quarterly revenue growth grew by 43.6%, now sitting on 110.1M for the twelve trailing months.

Volume

Today's last reported volume for Summit Financial Group is 9939 which is 26.83% below its average volume of 13584.

Summit Financial Group's sales growth is a negative 0% for the ongoing quarter and 19.1% for the next. The company's growth estimates for the present quarter and the next is 44.4% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.53%.

Volatility

Summit Financial Group's last day, last week, and last month's current volatility was 0.76%, 1.25%, and 1.63%, respectively.

Summit Financial Group's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.37% (day), 2.79% (last week), and 2.81% (last month), respectively.

Summit Financial Group's Stock Yearly Top and Bottom Value

Summit Financial Group's stock is valued at $22.50 at 23:22 EST, way under its 52-week high of $27.40 and way above its 52-week low of $14.31.

Summit Financial Group's Moving Average

Summit Financial Group's value is under its 50-day moving average of $22.87 and below its 200-day moving average of $23.91.

3. Cooper Companies (COO)

9.8% sales growth and 48.11% return on equity

The Cooper Companies, Inc. operates as a medical device company worldwide.

Cooper Companies's sales growth this year is anticipated to be 18.3% and 6.7% for next year.

Year-on-year quarterly revenue growth grew by 37.1%, now sitting on 2.66B for the twelve trailing months.

Volume

Today's last reported volume for Cooper Companies is 155990 which is 43.21% below its average volume of 274661.

Cooper Companies's sales growth is a negative 0% for the current quarter and 9.8% for the next. The company's growth estimates for the ongoing quarter and the next is 44.3% and 10.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.11%.

Volatility

Cooper Companies's last day, last week, and last month's current volatility was 0.68%, 0.44%, and 0.71%, respectively.

Cooper Companies's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.40% (day), 1.06% (last week), and 1.41% (last month), respectively.

Cooper Companies's Stock Yearly Top and Bottom Value

Cooper Companies's stock is valued at $403.89 at 23:22 EST, below its 52-week high of $415.96 and way above its 52-week low of $277.83.

Cooper Companies's Moving Average

Cooper Companies's worth is above its 50-day moving average of $391.97 and higher than its 200-day moving average of $386.67.

4. Cognizant Technology Solutions (CTSH)

7.4% sales growth and 14.13% return on equity

Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally.

Cognizant Technology Solutions's sales growth this year is anticipated to be 8.1% and 5.9% for next year.

Year-on-year quarterly revenue growth grew by 4.2%, now sitting on 16.83B for the twelve trailing months.

Volume

Today's last reported volume for Cognizant Technology Solutions is 1964570 which is 50.67% below its average volume of 3982530.

Cognizant Technology Solutions's sales growth is a negative 0% for the present quarter and 7.4% for the next. The company's growth estimates for the ongoing quarter and the next is 17.1% and 4.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.13%.

Volatility

Cognizant Technology Solutions's last day, last week, and last month's current volatility was 0.86%, 0.63%, and 0.83%, respectively.

Cognizant Technology Solutions's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.51% (day), 1.31% (last week), and 1.30% (last month), respectively.

Cognizant Technology Solutions's Stock Yearly Top and Bottom Value

Cognizant Technology Solutions's stock is valued at $68.24 at 23:22 EST, way below its 52-week high of $82.73 and way higher than its 52-week low of $60.80.

Cognizant Technology Solutions's Moving Average

Cognizant Technology Solutions's value is under its 50-day moving average of $70.05 and under its 200-day moving average of $75.50.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com